President Joe Biden currently holds a 48% approval rating in the latest poll from Quinnipiac University taken almost 100 days since he entered the White House, and has a 42% disapproval rating.
Quinnipiac found that the vast majority of Democrats approve of Biden’s performance, at 94%, while most Republicans disapprove, at 87%, with 45% of independents approving and 40% disapproving.
When asked about specific issues, Biden won the highest approval for his response to the COVID-19 pandemic, the economy, and climate change, with the lowest approval coming for his work on taxes, gun policy, and the southern border.
- 64% approve of Biden’s COVID-19 response, 42% disapprove.
- 50% approve of Biden’s work on the economy, 42% disapprove.
- 48% approve of Biden’s climate change efforts, 35% disapprove.
- 45% approve of Biden’s tax work, 42% disapprove.
- 39% approve of Biden’s gun policy, 49% disapprove.
- 29% approve of Biden’s handling of the border, 55% disapprove.
Quinnipiac University Polling Analyst Tim Malloy noted, “Though he gets generally positive numbers on his domestic strides as he nears his first 100 days in office, the president is confronting the same political quagmire south of the border that bedeviled his predecessor. The border with Mexico, and the people trying to cross it, loom as a familiar crisis.”
Most Americans said that Biden has good leadership skills, 52% to 44%, and that he is doing more to unite the country than divide it, 51% to 41%.
The poll also found that most Americans, 44%, support Biden’s $2.25 trillion infrastructure plan, and that even more approve if it’s funded by raising taxes on corporations, as the president has suggested.
“The president’s infrastructure bill, a $2 trillion national makeover, gets a lukewarm go ahead from Americans, but a warmer reception when the suggestion that big corporations, not taxpayers, should be forced to front the funding,” Malloy said.
Quinnipiac also polled Americans on their views of the COVID-19 vaccine, and found that more than 1-in-4 Americans said they have no plans to get the vaccine, while just over two-thirds have already been vaccinated or plan to be.
Malloy questioned whether the recent call for a pause on the use of the COVID-19 vaccine from Johnson & Johnson could cause that number to rise.
“About one-quarter of American adults already aren’t planning on getting a COVID-19 vaccine — but will the J&J vaccine announcement increase that number? Only time will tell,” added Malloy.
Quinnipiac polled 1,237 adults across the country from April 8-12, with a margin of error of +/- 2.8 percentage points.
Source: Newmax
